Discovering new treatments and developing new ways to diagnose and prevent Atrial Fibrillation is at the core of the CARMA Center’s research mission. By building collaborative relationships across a diverse group of clinicians and scientists, the CARMA Center is forging new paths in clinical trial research and potential drug therapies.
Discovering new treatments and developing new ways to diagnose and prevent Atrial Fibrillation is at the core of the CARMA Center’s research mission. By building collaborative relationships across a diverse group of clinicians and scientists, the CARMA Center is forging new paths in all areas of clinical research from developing new classification systems to new technologies to better treat and manage cardiac arrhythmia patients.
The CARMA Center team understands that imaging technology and software applications are an essential component to the successful diagnoses and treatment of Atrial Fibrillation and other heart rhythm diseases. Developing new technologies to improve and personalize the diagnosis, treatment and management of cardiac arrhythmias is the key to translating our research into clinical practice.
Thank you for your interest in the University of Utah School of Medicine. Outstanding clinicians, scientists, and educators work together to provide the highest quality medical education in a stimulating, enriching, and enjoyable environment.
Utah Multidisciplinary Arrhythmia Collaboration (UMAC) Atrial fibrillation (AF) is the most common arrhythmia affecting millions of Americans and costing billions of dollars in health care costs. Recent development in clinical cardiac electrophysiology have led to improved treatment options for patient with AF, success rates for drug therapy or interventional procedures are still far from optimal. With this project, we are developing animal models of AF in order to study the structural and electrophysiological changes that lead to and accompany AF. We are using state of the art MRI imaging, clinical electrical mapping, histology, and other techniques to investigate the changes in cardiac tissue as AF develops in normal, healthy hearts and becomes permanent in diseased hearts. This revolutionary project will illuminate conditions that lead to AF, improve clinicians ability to select appropriate treatments for patients’ specific AF substrates, and aid in the development of improved AF treatment options for AF patients.
CARMA Center 30 N 1900 E, Room 4A100 Salt Lake City, UT 84132